Tarlatamab Gets Priority Review for Advanced Small Cell Lung Cancer
The FDA has accepted for Priority Review the BLA for tarlatamab for adults with relapsed or refractory SCLC.
Source: empr.com
Page 49 - Priority Review News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Priority Review Today - Breaking & Trending Today
The Skanner News - FDA Approves Groundbreaking Cell-Based Gene Therapies for Sickle Cell Disease
Sickle cell disease, a group of inherited blood disorders, affects around 100,000 individuals in the United States and is predominant among African Americans.
Source: theskanner.com
Numinus Congratulates MAPS on its Application to the FDA for MDMA-Assisted Therapy for PTSD
VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ - Numinus Wellness Inc. , a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies,...
Source: marketscreener.com
FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the Company's...
Source: prnewswire.com
Biotech Seeks Approval of Synthetic Blood Vessel Graft
Biotech Seeks Approval of Synthetic Blood Vessel Graft
Source: investorideas.com